Your browser doesn't support javascript.
loading
Transient dominant host-range selection using Chinese hamster ovary cells to generate marker-free recombinant viral vectors from vaccinia virus.
Liu, Liang; Cooper, Tamara; Eldi, Preethi; Garcia-Valtanen, Pablo; Diener, Kerrilyn R; Howley, Paul M; Hayball, John D.
Afiliação
  • Liu L; Experimental Therapeutics Laboratory, Hanson Institute and Sansom Institute, Adelaide, Australia.
  • Cooper T; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.
  • Eldi P; Experimental Therapeutics Laboratory, Hanson Institute and Sansom Institute, Adelaide, Australia.
  • Garcia-Valtanen P; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.
  • Diener KR; Experimental Therapeutics Laboratory, Hanson Institute and Sansom Institute, Adelaide, Australia.
  • Howley PM; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.
  • Hayball JD; Experimental Therapeutics Laboratory, Hanson Institute and Sansom Institute, Adelaide, Australia.
Biotechniques ; 62(4): 183-187, 2017 04 01.
Article em En | MEDLINE | ID: mdl-28403810
ABSTRACT
Recombinant vaccinia viruses (rVACVs) are promising antigen-delivery systems for vaccine development that are also useful as research tools. Two common methods for selection during construction of rVACV clones are (i) co-insertion of drug resistance or reporter protein genes, which requires the use of additional selection drugs or detection methods, and (ii) dominant host-range selection. The latter uses VACV variants rendered replication-incompetent in host cell lines by the deletion of host-range genes. Replicative ability is restored by co-insertion of the host-range genes, providing for dominant selection of the recombinant viruses. Here, we describe a new method for the construction of rVACVs using the cowpox CP77 protein and unmodified VACV as the starting material. Our selection system will expand the range of tools available for positive selection of rVACV during vector construction, and it is substantially more high-fidelity than approaches based on selection for drug resistance.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Recombinação Genética / Vaccinia virus / Resistência a Medicamentos Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Recombinação Genética / Vaccinia virus / Resistência a Medicamentos Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article